Adcentrx Therapeutics Announces Formation of Scientific Advisory Board
ZYME Stock | USD 14.50 0.41 2.91% |
About 55% of Zymeworks Common's investor base is interested to short. The analysis of the overall investor sentiment regarding Zymeworks Common Stock suggests that many traders are impartial. The current market sentiment, together with Zymeworks Common's historical and current headlines, can help investors time the market. In addition, many technical investors use Zymeworks Common Stock stock news signals to limit their universe of possible portfolio assets.
Zymeworks |
Adcentrx Therapeutics , a clinical-stage biotechnology company focused on accelerating breakthroughs in developing protein conjugate therapeutics for cancer and other life-threatening diseases, today announces the formation of its Scientific Advisory Board to support the advancement of its innovative Antibody-Drug Conjugate technology platform and pipeline, including ADRX-0706, a Nectin-4 targeting ADC therapeutic currently being evaluated in a Phase 1ab clinical trial.
Read at finance.yahoo.com
Zymeworks Common Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Zymeworks Common can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Zymeworks Common Fundamental Analysis
We analyze Zymeworks Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zymeworks Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zymeworks Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Shares Shorted
Number Of Shares Shorted Comparative Analysis
Zymeworks Common is currently under evaluation in number of shares shorted category among its peers. Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
Zymeworks Common Stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zymeworks Common stock to make a market-neutral strategy. Peer analysis of Zymeworks Common could also be used in its relative valuation, which is a method of valuing Zymeworks Common by comparing valuation metrics with similar companies.
Peers
Zymeworks Common Related Equities
CABA | Cabaletta Bio | 8.12 | ||||
APLS | Apellis Pharmaceuticals | 4.39 | ||||
TVTX | Travere Therapeutics | 4.04 | ||||
INZY | Inozyme Pharma | 2.95 | ||||
BLUE | Bluebird Bio | 2.44 | ||||
ZNTL | Zentalis Pharmaceuticals | 1.39 | ||||
BPMC | Blueprint Medicines | 1.29 | ||||
ARWR | Arrowhead Pharmaceuticals | 1.19 | ||||
MRSN | Mersana Therapeutics | 0.88 | ||||
SNDX | Syndax Pharmaceuticals | 0.12 | ||||
AKRO | Akero Therapeutics | 0.28 | ||||
STOK | Stoke Therapeutics | 0.33 | ||||
RLAY | Relay Therapeutics | 0.64 | ||||
DAWN | Day One | 0.65 | ||||
YMAB | Y MAbs | 1.09 | ||||
PTGX | Protagonist Therapeutics | 1.23 | ||||
TERN | Terns Pharmaceuticals | 1.44 | ||||
EDIT | Editas Medicine | 2.23 | ||||
ANNX | Annexon | 2.23 | ||||
CYTK | Cytokinetics | 2.37 | ||||
PRQR | ProQR Therapeutics | 2.86 | ||||
ALEC | Alector | 3.09 | ||||
RVMD | Revolution Medicines | 10.46 |
Complementary Tools for Zymeworks Stock analysis
When running Zymeworks Common's price analysis, check to measure Zymeworks Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zymeworks Common is operating at the current time. Most of Zymeworks Common's value examination focuses on studying past and present price action to predict the probability of Zymeworks Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zymeworks Common's price. Additionally, you may evaluate how the addition of Zymeworks Common to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |